Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (461-470 of 542) with videos related to

Pageof 55
Sort By:
Journal of Clinical Microbiology|July 2, 2010
Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)A Espinel-Ingroff, D J Diekema, A Fothergill, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2000
Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamaseP L Winokur, A Brueggemann, D L DeSalvo, et al.
Journal of Clinical Microbiology|December 14, 2007
Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005M A Pfaller, D J Diekema, D L Gibbs, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 1, 2011
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteriaM A Pfaller, D J Diekema, D Andes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1996
Vertical and horizontal transmission of unique Candida species to premature newbornsL A Waggoner-Fountain, M W Walker, R J Hollis, et al.
The New England Journal of Medicine|July 9, 1992
Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care unitsB N Doebbeling, G L Stanley, C T Sheetz, et al.
Journal of Clinical Microbiology|April 9, 2004
Quality control limits for voriconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blueM A Pfaller, A Barry, J Bille, et al.
Journal of Clinical Microbiology|September 8, 2005
Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative studyA Espinel-Ingroff, F Barchiesi, M Cuenca-Estrella, et al.
Journal of Clinical Microbiology|October 20, 2006
Interlaboratory study of quality control isolates for a broth microdilution method (modified CLSI M38-A) for testing susceptibilities of dermatophytes to antifungalsM A Ghannoum, B Arthington-Skaggs, V Chaturvedi, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998M A Pfaller, R N Jones, G V Doern, et al.
Pageof 55

Showing results (461-470 of 542) with videos related to

Sort By:
Pageof 55
Journal of Clinical Microbiology|July 2, 2010
Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)A Espinel-Ingroff, D J Diekema, A Fothergill, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2000
Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamaseP L Winokur, A Brueggemann, D L DeSalvo, et al.
Journal of Clinical Microbiology|December 14, 2007
Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005M A Pfaller, D J Diekema, D L Gibbs, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 1, 2011
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteriaM A Pfaller, D J Diekema, D Andes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1996
Vertical and horizontal transmission of unique Candida species to premature newbornsL A Waggoner-Fountain, M W Walker, R J Hollis, et al.
The New England Journal of Medicine|July 9, 1992
Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care unitsB N Doebbeling, G L Stanley, C T Sheetz, et al.
Journal of Clinical Microbiology|April 9, 2004
Quality control limits for voriconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blueM A Pfaller, A Barry, J Bille, et al.
Journal of Clinical Microbiology|September 8, 2005
Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative studyA Espinel-Ingroff, F Barchiesi, M Cuenca-Estrella, et al.
Journal of Clinical Microbiology|October 20, 2006
Interlaboratory study of quality control isolates for a broth microdilution method (modified CLSI M38-A) for testing susceptibilities of dermatophytes to antifungalsM A Ghannoum, B Arthington-Skaggs, V Chaturvedi, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998M A Pfaller, R N Jones, G V Doern, et al.
Pageof 55